Global and United States Prostate Cancer Nuclear Medicine Diagnostics Market Report & Forecast 2023-2028

Report ID: 1823534 | Published Date: Apr 2026 | No. of Page: 97 | Base Year: 2025 | Rating: 3.8
Request Sample Report
Pre-Order Enquiry 
1 Study Coverage
    1.1 Prostate Cancer Nuclear Medicine Diagnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size for the Year 2017-2028
        1.2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size for the Year 2017-2028
    1.3 Prostate Cancer Nuclear Medicine Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Prostate Cancer Nuclear Medicine Diagnostics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Prostate Cancer Nuclear Medicine Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Prostate Cancer Nuclear Medicine Diagnostics Market Dynamics
        1.4.1 Prostate Cancer Nuclear Medicine Diagnostics Industry Trends
        1.4.2 Prostate Cancer Nuclear Medicine Diagnostics Market Drivers
        1.4.3 Prostate Cancer Nuclear Medicine Diagnostics Market Challenges
        1.4.4 Prostate Cancer Nuclear Medicine Diagnostics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Prostate Cancer Nuclear Medicine Diagnostics by Type
    2.1 Prostate Cancer Nuclear Medicine Diagnostics Market Segment by Type
        2.1.1 SPECT
        2.1.2 PET
    2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2028)
    2.4 United States Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2028)
3 Prostate Cancer Nuclear Medicine Diagnostics by Application
    3.1 Prostate Cancer Nuclear Medicine Diagnostics Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Others
    3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2028)
    3.4 United States Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2028)
4 Global Prostate Cancer Nuclear Medicine Diagnostics Competitor Landscape by Company
    4.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Company
        4.1.1 Top Global Prostate Cancer Nuclear Medicine Diagnostics Companies Ranked by Revenue (2021)
        4.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Player (2017-2022)
    4.2 Global Prostate Cancer Nuclear Medicine Diagnostics Concentration Ratio (CR)
        4.2.1 Prostate Cancer Nuclear Medicine Diagnostics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Prostate Cancer Nuclear Medicine Diagnostics in 2021
        4.2.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Prostate Cancer Nuclear Medicine Diagnostics Headquarters, Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Prostate Cancer Nuclear Medicine Diagnostics Headquarters and Area Served
        4.3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Companies Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Prostate Cancer Nuclear Medicine Diagnostics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Prostate Cancer Nuclear Medicine Diagnostics Market Size by Company
        4.5.1 Top Prostate Cancer Nuclear Medicine Diagnostics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Prostate Cancer Nuclear Medicine Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region
    5.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2017-2028)
        5.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region: 2017-2022
        5.2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth 2017-2028
        6.1.2 North America Prostate Cancer Nuclear Medicine Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth 2017-2028
        6.3.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Blue Earth Diagnostics
        7.1.1 Blue Earth Diagnostics Company Details
        7.1.2 Blue Earth Diagnostics Business Overview
        7.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Introduction
        7.1.4 Blue Earth Diagnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        7.1.5 Blue Earth Diagnostics Recent Development
    7.2 PETNET Solutions
        7.2.1 PETNET Solutions Company Details
        7.2.2 PETNET Solutions Business Overview
        7.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Introduction
        7.2.4 PETNET Solutions Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        7.2.5 PETNET Solutions Recent Development
    7.3 Cardinal Health
        7.3.1 Cardinal Health Company Details
        7.3.2 Cardinal Health Business Overview
        7.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Introduction
        7.3.4 Cardinal Health Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        7.3.5 Cardinal Health Recent Development
    7.4 Lantheus Medical Imaging
        7.4.1 Lantheus Medical Imaging Company Details
        7.4.2 Lantheus Medical Imaging Business Overview
        7.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Introduction
        7.4.4 Lantheus Medical Imaging Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        7.4.5 Lantheus Medical Imaging Recent Development
    7.5 Jubilant Pharma
        7.5.1 Jubilant Pharma Company Details
        7.5.2 Jubilant Pharma Business Overview
        7.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
        7.5.4 Jubilant Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        7.5.5 Jubilant Pharma Recent Development
    7.6 NCM-USA
        7.6.1 NCM-USA Company Details
        7.6.2 NCM-USA Business Overview
        7.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Introduction
        7.6.4 NCM-USA Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        7.6.5 NCM-USA Recent Development
    7.7 Progenics Pharma
        7.7.1 Progenics Pharma Company Details
        7.7.2 Progenics Pharma Business Overview
        7.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
        7.7.4 Progenics Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        7.7.5 Progenics Pharma Recent Development
    7.8 Telix Pharma
        7.8.1 Telix Pharma Company Details
        7.8.2 Telix Pharma Business Overview
        7.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
        7.8.4 Telix Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        7.8.5 Telix Pharma Recent Development
    7.9 ImaginAb
        7.9.1 ImaginAb Company Details
        7.9.2 ImaginAb Business Overview
        7.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Introduction
        7.9.4 ImaginAb Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        7.9.5 ImaginAb Recent Development
    7.10 Theragnostics
        7.10.1 Theragnostics Company Details
        7.10.2 Theragnostics Business Overview
        7.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Introduction
        7.10.4 Theragnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        7.10.5 Theragnostics Recent Development
    7.11 Novartis
        7.11.1 Novartis Company Details
        7.11.2 Novartis Business Overview
        7.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Introduction
        7.11.4 Novartis Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        7.11.5 Novartis Recent Development
    7.12 Alliance Medical
        7.12.1 Alliance Medical Company Details
        7.12.2 Alliance Medical Business Overview
        7.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Introduction
        7.12.4 Alliance Medical Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        7.12.5 Alliance Medical Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Prostate Cancer Nuclear Medicine Diagnostics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Prostate Cancer Nuclear Medicine Diagnostics Market Trends
    Table 3. Prostate Cancer Nuclear Medicine Diagnostics Market Drivers
    Table 4. Prostate Cancer Nuclear Medicine Diagnostics Market Challenges
    Table 5. Prostate Cancer Nuclear Medicine Diagnostics Market Restraints
    Table 6. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Prostate Cancer Nuclear Medicine Diagnostics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Player, 2017-2022
    Table 13. Global Prostate Cancer Nuclear Medicine Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Prostate Cancer Nuclear Medicine Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Nuclear Medicine Diagnostics as of 2021)
    Table 15. Top Players of Prostate Cancer Nuclear Medicine Diagnostics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Prostate Cancer Nuclear Medicine Diagnostics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Prostate Cancer Nuclear Medicine Diagnostics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Prostate Cancer Nuclear Medicine Diagnostics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Prostate Cancer Nuclear Medicine Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Prostate Cancer Nuclear Medicine Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Prostate Cancer Nuclear Medicine Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Blue Earth Diagnostics Company Details
    Table 31. Blue Earth Diagnostics Business Overview
    Table 32. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 33. Blue Earth Diagnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 34. Blue Earth Diagnostics Recent Development
    Table 35. PETNET Solutions Company Details
    Table 36. PETNET Solutions Business Overview
    Table 37. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 38. PETNET Solutions Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 39. PETNET Solutions Recent Development
    Table 40. Cardinal Health Company Details
    Table 41. Cardinal Health Business Overview
    Table 42. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 43. Cardinal Health Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 44. Cardinal Health Recent Development
    Table 45. Lantheus Medical Imaging Company Details
    Table 46. Lantheus Medical Imaging Business Overview
    Table 47. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 48. Lantheus Medical Imaging Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 49. Lantheus Medical Imaging Recent Development
    Table 50. Jubilant Pharma Company Details
    Table 51. Jubilant Pharma Business Overview
    Table 52. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 53. Jubilant Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 54. Jubilant Pharma Recent Development
    Table 55. NCM-USA Company Details
    Table 56. NCM-USA Business Overview
    Table 57. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 58. NCM-USA Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 59. NCM-USA Recent Development
    Table 60. Progenics Pharma Company Details
    Table 61. Progenics Pharma Business Overview
    Table 62. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 63. Progenics Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 64. Progenics Pharma Recent Development
    Table 65. Telix Pharma Company Details
    Table 66. Telix Pharma Business Overview
    Table 67. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 68. Telix Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 69. Telix Pharma Recent Development
    Table 70. ImaginAb Company Details
    Table 71. ImaginAb Business Overview
    Table 72. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 73. ImaginAb Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 74. ImaginAb Recent Development
    Table 75. Theragnostics Company Details
    Table 76. Theragnostics Business Overview
    Table 77. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 78. Theragnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 79. Theragnostics Recent Development
    Table 80. Novartis Company Details
    Table 81. Novartis Business Overview
    Table 82. Novartis Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 83. Novartis Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 84. Novartis Recent Development
    Table 85. Alliance Medical Company Details
    Table 86. Alliance Medical Business Overview
    Table 87. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 88. Alliance Medical Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 89. Alliance Medical Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Prostate Cancer Nuclear Medicine Diagnostics Product Picture
    Figure 2. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Prostate Cancer Nuclear Medicine Diagnostics Market Share in Global 2017-2028
    Figure 7. Prostate Cancer Nuclear Medicine Diagnostics Report Years Considered
    Figure 8. Product Picture of SPECT
    Figure 9. Product Picture of PET
    Figure 10. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type in 2022 & 2028
    Figure 11. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2017-2028)
    Figure 13. United States Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type in 2022 & 2028
    Figure 14. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Clinics
    Figure 18. Product Picture of Others
    Figure 19. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application in 2022 & 2028
    Figure 20. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2017-2028)
    Figure 22. United States Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application in 2022 & 2028
    Figure 23. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2017-2028)
    Figure 25. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Blue Earth Diagnostics Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 54. PETNET Solutions Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 55. Cardinal Health Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 56. Lantheus Medical Imaging Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 57. Jubilant Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 58. NCM-USA Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 59. Progenics Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 60. Telix Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 61. ImaginAb Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 62. Theragnostics Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 63. Novartis Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 64. Alliance Medical Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Blue Earth Diagnostics
PETNET Solutions
Cardinal Health
Lantheus Medical Imaging
Jubilant Pharma
NCM-USA
Progenics Pharma
Telix Pharma
ImaginAb
Theragnostics
Novartis
Alliance Medical
Frequently Asked Questions
Prostate Cancer Nuclear Medicine Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate Cancer Nuclear Medicine Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate Cancer Nuclear Medicine Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Medical Writing

Medical Writing market is segmented by region (country), players, by Type and by Application. Pla ... Read More